CURO Biosciences Secures ₹16 cr for advancing saliva-based cancer detection tech

ErlySign’s innovation is a biomarker-based test kit capable of detecting oral precancerous conditions within just 15 minutes using a simple, non-invasive saliva sample.

from Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/2ARLBFD
at
Healthcare, Pharma, Medical , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Elsevier launches GenAI tool to streamline literature review process for researchers

ScienceDirect AI is a generative AI-powered tool that provides trusted insights by extracting, summarising, and comparing information from m...